These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19701044)

  • 1. Effect of mifepristone on abortion access in the United States.
    Finer LB; Wei J
    Obstet Gynecol; 2009 Sep; 114(3):623-630. PubMed ID: 19701044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accessibility of abortion services in the United States, 2001.
    Henshaw SK; Finer LB
    Perspect Sex Reprod Health; 2003; 35(1):16-24. PubMed ID: 12602753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abortion incidence and services in the United States in 2000.
    Finer LB; Henshaw SK
    Perspect Sex Reprod Health; 2003; 35(1):6-15. PubMed ID: 12602752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abortion incidence and services in the United States, 1995-1996.
    Henshaw SK
    Fam Plann Perspect; 1998; 30(6):263-70, 287. PubMed ID: 9859016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating abortion provision and abortion referrals among United States obstetrician-gynecologists in private practice.
    Desai S; Jones RK; Castle K
    Contraception; 2018 Apr; 97(4):297-302. PubMed ID: 29174883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are US health professionals likely to prescribe mifepristone or methotrexate?
    Koenig JD; Tapias MP; Hoff T; Stewart FH
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):155-60. PubMed ID: 10846327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical abortion practices: a survey of National Abortion Federation members in the United States.
    Wiegerinck MM; Jones HE; O'Connell K; Lichtenberg ES; Paul M; Westhoff CL
    Contraception; 2008 Dec; 78(6):486-91. PubMed ID: 19014795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Providing controversial health care: abortion services since 1973.
    Forrest JD; Henshaw SK
    Womens Health Issues; 1993; 3(3):152-7. PubMed ID: 8274870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abortion in the United States: incidence and access to services, 2005.
    Jones RK; Zolna MR; Henshaw SK; Finer LB
    Perspect Sex Reprod Health; 2008 Mar; 40(1):6-16. PubMed ID: 18318867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abortion reporting in the era of medical procedures: why is it important?
    Koonin LM
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):203-4. PubMed ID: 10846340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abortion services in the United States, 1981 and 1982.
    Henshaw SK; Forrest JD; Blaine E
    Fam Plann Perspect; 1984; 16(3):119-27. PubMed ID: 6468641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.
    Pazol K; Creanga AA; Zane SB
    Contraception; 2012 Dec; 86(6):746-51. PubMed ID: 22770796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors hindering access to abortion services.
    Henshaw SK
    Fam Plann Perspect; 1995; 27(2):54-9, 87. PubMed ID: 7796896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France.
    Gaudu S; Crost M; Esterle L
    Contraception; 2013 Jan; 87(1):45-50. PubMed ID: 22898363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Legislation Regulating Abortion in Arizona.
    Williams SG; Roberts S; Kerns JL
    Womens Health Issues; 2018; 28(4):297-300. PubMed ID: 29631976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abortion Incidence and Service Availability In the United States, 2014.
    Jones RK; Jerman J
    Perspect Sex Reprod Health; 2017 Mar; 49(1):17-27. PubMed ID: 28094905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has mifepristone medical abortion expanded abortion access in New Mexico? A survey of OB-GYN and Family Medicine physicians.
    Espey E; Leeman L; Ogburn T; Skipper B; Eyman C; North M
    Contraception; 2011 Aug; 84(2):178-83. PubMed ID: 21757060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.